Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06377371 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv6
  2. Primary and study completion dates: Jan 2025 to Jan 2027v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 2024 to Sep 11, 2024
    • Site details revised
    v4
  4. Start date: May 2024 to Jul 2024v3
  5. Start date: Apr 2024 to May 2024
    • Study description expanded, about 42 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study team hypothesizes that it is feasible to intraoperatively detect tumor following \[CU64\]DOTATATE injection using the gamma probe device.
Trial Details
NCT Number NCT06377371
Lead Sponsor Weill Medical College of Cornell University
Collaborators: Curium US LLC
Conditions
(from sponsor)		 Meningioma
Related terms Meningioma
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov